Head-to-head · WeighScore
GOAL.MD vs ShedRx
By GLP-1 ScorecardUpdated
Score comparison
ShedRx has the higher recorded score — 87/100 to 68.6/100.
ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Shed combines compounded injections and branded Wegovy/Zepbound options with coaching; compare longer-plan supply, fees and guarantee rules before committing.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | GOAL.MD | ShedRx |
|---|---|---|
| WeighScore | 68.6/100 | 87/100 |
| Grade | C | B+ |
| Site position | #159 | #3 |
| Semaglutide | $179/mo (month-to-month, compounded) | $199/mo |
| Tirzepatide | $249/mo (flat-dose monthly, compounded) | $299/mo |
| Coverage | Advertises all 50 states; clinical and pharmacy eligibility apply | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #159 · C
Strengths
- Compounded reorders require permission before charging
- Advertised injection price stays the same across prescribed doses
- Nutrition support and expedited shipping included in compounded plans
- Advertises brand-name oral Wegovy access; medication costs extra
What to consider
- Compounded orders become non-refundable when payment is processed
- Lowest monthly equivalents require a twelve-month upfront payment
- Brand-access page gives conflicting automatic-billing statements
- Confirm the assigned dispensing pharmacy and its credentials
- GOAL identifies a physician with historical discipline; Missouri ended restrictions in 2019 and records no current discipline at the October 2026 check
Site position #3 · B+
Strengths
- Published injection plans plus other formulation and branded prescribing options
- One-month injection prices listed at $199 semaglutide / $299 tirzepatide
- Terms describe monthly coaching and name six possible pharmacy partners
What to consider
- Six- and twelve-month plans specify 24 and 48 weeks of medication
- The 120-day promise has first-time-user and participation requirements and does not cancel a longer plan
- Branded pages display conflicting $99/$125 membership charges, with medication separate
- Actual clinician/pharmacy assignment and the applicable minimum term need confirmation
Featured provider
ShedRx
ShedRx scores 87/100 (B+). Shed combines compounded injections and branded Wegovy/Zepbound options with coaching; compare longer-plan supply, fees and guarantee rules before committing.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.